Midazolam Autoinjectors Project Bioshield has been closed on 30 Jul 2021.
It no longer accepts any bids. For further information,
you can contact the HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.ASPR BARDA DIV CONTRACTS MGMT & ACQ
Bellow, you can find more information about this project:
General information
Donor:
HEALTH AND HUMAN SERVICES, DEPARTMENT OF.OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE.ASPR BARDA DIV CONTRACTS MGMT & ACQ
This Request for Proposal (RFP) covers the advanced research and development, procurement, and delivery of adult and pediatric midazolam autoinjectors that have received FDA approval for the treatment of status epilepticus seizures (including seizures caused by nerve agents) in adult and pediatric populations (2+ years of age).